Risk of new malignancies following breast cancer: tissue sub-study

Ended Purchase Order Awarded Last action

Contract number
75N91018P00731
Awardee
Awarding agency
Obligated
$24,999

Award facts

Contract value 100% obligated
$24,999.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98101, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Kaiser Foundation Health Plan of Washington valued at $24,999.00 on September 14, 2018, for a tissue sub-study examining the risk of new malignancies following breast cancer. Work is performed in Seattle, Washington. The order carries a firm fixed price and has an ultimate completion date of September 13, 2019.

Quick answers

Who was awarded contract 75N91018P00731?

75N91018P00731 was awarded to Kaiser Foundation Health Plan Of Washington by National Cancer Institute (National Institutes of Health) on September 14, 2018.

How much is contract 75N91018P00731 worth?

The government has obligated $24,999 on 75N91018P00731.

Was contract 75N91018P00731 competed?

The extent of competition for 75N91018P00731 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award